Startseite Influence of topical iodine-containing antiseptics used during delivery on recall rate of congenital hypothyroidism screening program
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Influence of topical iodine-containing antiseptics used during delivery on recall rate of congenital hypothyroidism screening program

  • Majid Valizadeh , Farzaneh Moezzi , Zohreh Khavassi , Mohammad Movahedinia ORCID logo EMAIL logo , Seideh Mazloomzadeh und Ladan Mehran
Veröffentlicht/Copyright: 15. August 2017

Abstract

Background:

The proportion of newborns recalled during neonatal screening programs for congenital hypothyroidism (CH) varies substantially by country and may be higher in settings where povodine iodine (PVP-I) is used during delivery. We assessed this hypothesis by substituting PVP-I for chlorhexidine (CHL) and evaluated the reduction in the recall rate of the Irainian newborn screening program.

Methods:

This study investigated 2282 neonates of mothers admitted to a local hospital for delivery between December 2012 and October 2013. We measured thyorid stimulating hormone (TSH) levels in heel-prick blood specimens of infants, aged between 3 and 5 days, born to mothers who received PVP-I (phase I) and those who received CHL after withdrawal of PVP-I from obstetric procedures (phase II). Then we compared the median TSH levels and the recall rate based on a TSH level ≥5 mU/L.

Results:

Of 2282 cases, 1094 infants were born to mothers exposed to PVP-I during phase I (PVP-I group) and 1188 ones were born to mothers exposed to chlorhexidine in phase II (CHL group); 6.56% of the PVP-I group and 1.91% of the CHL group were recalled later during screening (p<0.001). The median TSH level was significantly higher in the PVP-I group compared to the CHL group (1.35 vs. 1.00, p<0.001).

Conclusions:

Replacement of iodine-containing antiseptics by iodine-free ones, during delivery resulted in a significant reduction in the recall rate of the Iranian screening program for CH.

Acknowledgments

The authors wish to acknowledge Ms. Niloofar Shiva for critical editing of English grammar and syntax of the manuscript.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Chanoine J-P, Boulvain M, Bourdoux P, Pardou A, Van Thi HV, et al. Increased recall rate at screening for congenital hypothyroidism in breast fed infants born to iodine overloaded mothers. Arch Dis Child 1988;63:1207–10.10.1136/adc.63.10.1207Suche in Google Scholar

2. Fyrö K, Bodegård G. Four‐year follow‐up of psychological reactions to false positive screening tests for congenital hypothyroidism. Acta Paediatrica 1987;76:107–14.10.1111/j.1651-2227.1987.tb10424.xSuche in Google Scholar

3. Hashemipour M, Amini M, Iranpour R, Javadi A, Sadri GH, et al. High prevalence of congenital hypothyroidism in Isfahan, Iran. Iranian J Endocrinol Metab 2004;6:13–9.Suche in Google Scholar

4. Mengreli C, Kanaka-Gantenbein C, Girginoudis P, Magiakou M-A, Christakopoulou I, et al. Screening for congenital hypothyroidism: the significance of threshold limit in false-negative results. J Clin Endocrinol Metab 2010;95:4283–90.10.1210/jc.2010-0057Suche in Google Scholar

5. Valizadeh M, Mazloomzadeh S, Niksirat A, Shajari Z. High incidence and recall rate of congenital hypothyroidism in Zanjan province, a health problem or a study challenge? Int J Endocrinol Metab 2011;9:338–42.10.5812/Kowsar.1726913X.3639Suche in Google Scholar

6. Francis I, Weldon A, Connelly J. Effect of betadine treatment to umbilical cords on screening tests for congenital hypothyroidism. Neonatal Screening, Excerpta Medica, Amsterdam-Oxford-Princeton, 1983:52–3.Suche in Google Scholar

7. Grüters A, Lallemend D, Heideman P, Helge H. Thyroid function and iodine concentrations in newborns and their mothers after vaginal PVP-iodine treatment in obstetrics. Neonatal Screening, Excerpta Medica, Amsterdam-Oxford-Princeton, 1983:54–5.Suche in Google Scholar

8. Harada S, Ichihara N, Arai J, Honma H, Matsuura N, et al. Influence of iodine excess due to iodine-containing antiseptics on neonatal screening for congenital hypothyroidism in Hokkaido prefecture, Japan. Screening 1994;3:115–23.10.1016/0925-6164(94)90019-1Suche in Google Scholar

9. Ordookhani A, Pearce EN, Mirmiran P, Azizi F, Braverman LE. The effect of type of delivery and povidone-iodine application at delivery on cord dried-blood-specimen thyrotropin level and the rate of hyperthyrotropinemia in mature and normal-birth-weight neonates residing in an iodine-replete area: report of Tehran Province, 1998–2005. Thyroid 2007;17:1097–102.10.1089/thy.2007.0058Suche in Google Scholar PubMed

10. Nøhr SB, Laurberg P. Opposite variations in maternal and neonatal thyroid function Induced by Iodine supplementation during pregnancy 1. J Clin Endocrinol Metab 2000;85:623–7.10.1210/jc.85.2.623Suche in Google Scholar

11. Hashemipour M, Hovsepian S, Kelishadi R. High prevalence of congenital hypothyroidism in Isfahan: do familial components have a role? Adv Biomed Res 2012;1:37.10.4103/2277-9175.100130Suche in Google Scholar PubMed PubMed Central

12. Kliegman R, Behrman RE, Jenson HB, Stanton BF. Nelson textbook of pediatrics. Amsterdam, Netherlands: Elsevier Health Sciences, 2012.Suche in Google Scholar

13. McPherson RA, Pincus MR. Henry’s clinical diagnosis and management by laboratory methods. Amsterdam, Netherlands: Elsevier Health Sciences, 2011.Suche in Google Scholar

14. Rosenthal M, Addison GM, Price DA. Congenital hypothyroidism: increased incidence in Asian families. Arch Dis Child 1988;63:790–3.10.1136/adc.63.7.790Suche in Google Scholar PubMed PubMed Central

15. Cassio A, Colli C, Piazzi S, Bozza D, Zappulla F, et al. Results of screening of congenital hypothyroidism and iodine excess in neonatal age. Ann I Super Sanita 1998;34:337–41.Suche in Google Scholar

16. Koga Y, Sano H, Kikukawa Y, Ishigouoka T, Kawamura M. Effect on neonatal thyroid function of povidone-iodine used on mothers during perinatal period. J Obstet Gynaecol 1995;21:581–5.10.1111/j.1447-0756.1995.tb00916.xSuche in Google Scholar PubMed

17. Caldwell KL, Pan Y, Mortensen ME, Makhmudov A, Merrill L, et al. Iodine status in pregnant women in the National Children’s Study and in US women (15–44 years), National Health and Nutrition Examination Survey 2005–2010. Thyroid 2013;23:927–37.10.1089/thy.2013.0012Suche in Google Scholar PubMed PubMed Central

18. Nagendran V, Wicking J, Ekbote A, Onyekwe T, Garvey LH. IgE-mediated chlorhexidine allergy: a new occupational hazard? Occup Med 2009;59:270–2.10.1093/occmed/kqp042Suche in Google Scholar PubMed

19. Wittczak T, Dudek W, Walusiak-Skorupa J, Świerczyńska- Machura D, Pałczyński C. Chlorhexidine – still an underestimated allergic hazard for health care professionals. Occup Med 2013:63:301–5.10.1093/occmed/kqt035Suche in Google Scholar PubMed

Received: 2016-4-29
Accepted: 2017-7-17
Published Online: 2017-8-15
Published in Print: 2017-8-28

©2017 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Original Articles
  3. Standard body mass index reference data of prepubescent diabetic Egyptian children
  4. Frequency and risk factors of depression in type 1 diabetes in a developing country
  5. Association of obesity and health related quality of life in Iranian children and adolescents: the Weight Disorders Survey of the CASPIAN-IV study
  6. Association between urinary phthalates and metabolic abnormalities in obese Thai children and adolescents
  7. A pilot study of the effect of human breast milk on urinary metabolome analysis in infants
  8. Assessment of the correlation between the atherogenic index of plasma and cardiometabolic risk factors in children and adolescents: might it be superior to the TG/HDL-C ratio?
  9. Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency
  10. Application of povidone-iodine at delivery significantly increases maternal urinary iodine but not neonatal thyrotropin in an area with iodine sufficiency
  11. Influence of topical iodine-containing antiseptics used during delivery on recall rate of congenital hypothyroidism screening program
  12. Applying targeted next generation sequencing to dried blood spot specimens from suspicious cases identified by tandem mass spectrometry-based newborn screening
  13. Short Communication
  14. Initial patient choice of a growth hormone device improves child and adolescent adherence to and therapeutic effects of growth hormone replacement therapy
  15. Case Reports
  16. An occult ectopic parathyroid adenoma in a pediatric patient: a case report and management algorithm
  17. Fetal goitrous hypothyroidism treated by intra-amniotic levothyroxine administration: case report and review of the literature
  18. Carotid intima media thickness in a girl with sitosterolemia carrying a homozygous mutation in the ABCG5 gene
  19. Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism
Heruntergeladen am 26.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2016-0164/html
Button zum nach oben scrollen